P PFE

Pfizer Inc

DRUG MANUFACTURERS - GENERAL · HEALTHCARE

Pfizer Inc. is a leading global pharmaceutical and biotechnology company headquartered in New York City, boasting a distinguished history of innovation since 1849. With a comprehensive therapeutic portfolio that includes key areas such as immunology, oncology, and cardiology, Pfizer is committed to ...

$25.16

-0.36% ($0.09)

Volume 29.91M

52W High $28.75

52W Low $23.11

Market Cap $149.80B

← Back to Calendar Compare with Others →

Next Earnings Report

No earnings data available for PFE

Price Chart

EPS History: Consensus vs Actual

Last 10 quarters

Price Movement Around Earnings

Q1 2026 May 5, 2026

1-Day: +0.30%

Q1 2026 Apr 28, 2026

1-Day: -0.83%

Q4 2025 Feb 3, 2026

1-Day: +3.92%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q1'26	$14.45B	+5.4%	67.3%	27.9%	$2.69B
Q4'25	$17.56B	-1.2%	70.0%	21.0%	-$1.65B
Q3'25	$16.65B	-5.9%	75.0%	21.3%	$3.54B
Q2'25	$14.65B	+10.3%	64.3%	24.4%	$2.91B
Q1'25	$13.72B	-7.8%	71.7%	33.7%	$2.97B
Q4'24	$17.76B	+21.9%	73.0%	32.2%	$403.0M
Q3'24	$17.70B	+31.2%	60.9%	28.1%	$4.47B
Q2'24	$13.28B	+4.3%	62.1%	14.2%	$24.0M

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q2 2026	Jul 29, 2026	$0.68	$0.75	--	--	--
Q1 2026	May 5, 2026	$0.72	$0.83	$0.75	+4.17%	Missed
Q1 2026	Apr 28, 2026	$0.73	$0.84	--	--	--
Q4 2025	Feb 3, 2026	$0.57	$0.66	$0.66	+15.79%	Met
Q3 2025	Nov 4, 2025	$0.63	$0.72	$0.87	+38.10%	Beat
Q2 2025	Aug 5, 2025	$0.57	$0.41	$0.78	+36.84%	Beat
Q1 2025	Apr 29, 2025	$0.67	$0.77	$0.92	+37.31%	Beat
Q4 2024	Feb 4, 2025	$0.46	$0.53	$0.63	+36.96%	Beat
Q3 2024	Oct 29, 2024	$0.61	$0.70	$1.06	+73.77%	Beat
Q2 2024	Jul 30, 2024	$0.46	$0.53	$0.60	+30.43%	Beat
Q1 2024	May 1, 2024	$0.51	$0.59	$0.82	+60.78%	Beat
Q4 2023	Jan 30, 2024	-$0.18	-$0.18	$0.10	--	Beat